GH
Guardant Health, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$157.26
−2.35%1
Insider buys (3m)
38
Insider sells (3m)
-$81.1M
Net value (3m)
+20.2%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 24, 2026 | Talasaz AmirAli · director, officer: Co-Chief Executive Officer | Sale | 7,589 | $170 |
| Aug 24, 2026 | Talasaz AmirAli · director, officer: Co-Chief Executive Officer | Sale | 20,888 | $169 |
| Aug 24, 2026 | Talasaz AmirAli · director, officer: Co-Chief Executive Officer | Sale | 9,023 | $168 |
| Aug 24, 2026 | MIGNONE ROBERTO · director | M-Exempt | 264 | $0.00 |
| Aug 18, 2026 | Hidalgo Medina Manuel · director | M-Exempt | 232 | $0.00 |
| Aug 18, 2026 | Tariq Musa · director | Sale | 116 | $156 |
| Aug 18, 2026 | Tariq Musa · director | M-Exempt | 250 | $0.00 |
| Aug 13, 2026 | Monroe Terilyn J. · officer: Chief People Officer | Sale | 3,704 | $163 |
| Aug 13, 2026 | Monroe Terilyn J. · officer: Chief People Officer | Sale | 9,934 | $164 |
| Aug 13, 2026 | Monroe Terilyn J. · officer: Chief People Officer | Sale | 13,248 | $166 |
| Aug 13, 2026 | Monroe Terilyn J. · officer: Chief People Officer | Sale | 400 | $168 |
| Aug 13, 2026 | Monroe Terilyn J. · officer: Chief People Officer | M-Exempt | 32,288 | $20 |
| Aug 13, 2026 | Monroe Terilyn J. · officer: Chief People Officer | Sale | 19,014 | $165 |
| Aug 13, 2026 | Monroe Terilyn J. · officer: Chief People Officer | M-Exempt | 14,012 | $29 |
| Aug 11, 2026 | Freeman Chris · officer: Chief Commercial Officer | M-Exempt | 28,193 | $28 |
| Aug 11, 2026 | Freeman Chris · officer: Chief Commercial Officer | Sale | 17,413 | $170 |
| Aug 11, 2026 | Freeman Chris · officer: Chief Commercial Officer | M-Exempt | 35,412 | $110 |
| Aug 11, 2026 | Freeman Chris · officer: Chief Commercial Officer | Sale | 7,365 | $169 |
| Aug 11, 2026 | Freeman Chris · officer: Chief Commercial Officer | Sale | 35,364 | $170 |
| Aug 11, 2026 | Freeman Chris · officer: Chief Commercial Officer | Sale | 3,463 | $167 |
| Aug 6, 2026 | Hidalgo Medina Manuel · director | Sale | 750 | $165 |
| Aug 6, 2026 | Hidalgo Medina Manuel · director | Sale | 950 | $164 |
| Aug 6, 2026 | Hidalgo Medina Manuel · director | M-Exempt | 950 | $33 |
| Aug 5, 2026 | CLARK IAN T · director | M-Exempt | 6,833 | $51 |
| Aug 5, 2026 | CLARK IAN T · director | M-Exempt | 2,255 | $91 |
| Aug 5, 2026 | CLARK IAN T · director | Sale | 9,088 | $159 |
| Aug 5, 2026 | CLARK IAN T · director | Sale | 5,092 | $159 |
| Jul 22, 2026 | MIGNONE ROBERTO · director | M-Exempt | 264 | $0.00 |
| Jul 20, 2026 | Hidalgo Medina Manuel · director | M-Exempt | 232 | $0.00 |
| Jul 16, 2026 | Tariq Musa · director | M-Exempt | 250 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 230Increased 388Reduced 352Sold out 42
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Increased | 11,553,759 | May 13, 2026 |
| BlackRock, Inc. | Reduced | 7,622,935 | Aug 7, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 7,023,689 | May 15, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Reduced | 6,514,952 | Aug 14, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 5,837,992 | May 8, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 5,755,857 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 5,624,180 | May 15, 2026 |
| FMR LLC | Increased | 5,488,272 | Aug 13, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Reduced | 5,445,785 | Aug 13, 2026 |
| INVESCO LTD. | Reduced | 4,946,469 | May 12, 2026 |
| GOLDMAN SACHS GROUP INC | Reduced | 4,435,839 | May 15, 2026 |
| Invesco Ltd. | Reduced | 4,429,755 | Aug 14, 2026 |
| TWO SIGMA INVESTMENTS, LP | Increased | 4,229,531 | May 15, 2026 |
| FMR LLC | Increased | 4,116,081 | May 15, 2026 |
| BAILLIE GIFFORD & CO | Reduced | 3,859,046 | May 8, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 24, 2026